DPP-4 Inhibitors Can Cause Severe Joint Pain, FDA Says
However, the pain associated with dipeptidyl peptidase-4 inhibitors for type 2 diabetes goes away once patients stop taking the medicine, according to the agency. News Alerts …read more
Young Women Refuse Tamoxifen Because of Fertility Concerns
Concerns about fertility can influence adherence to endocrine therapy in young women with breast cancer, a new study suggests. Medscape Medical News …read more
Teens and Women Aged 35+ Least Likely to Use Contraception
Dr Peter Kovacs says that a new analysis of factors associated with nonuse of contraception can be used to identify women at risk for unplanned pregnancy. Medscape Ob/Gyn …read more
Oncotype DX Impacts Chemotherapy Decisions in Breast Cancer
A large cohort study demonstrated that Oncotype DX testing was associated with less frequent chemotherapy use in high-risk patients, but more frequent use in low-risk women. Medscape Medical News …read more
About 10 percent of mothers experienced depression 2 years after Hurricane Katrina, study shows
About 10 percent of mothers experienced chronic, persistent depressive symptoms two years after Hurricane Katrina slammed into the Gulf Coast, killing more than 1,800 people, displacing hundreds of… …read more
Growth hormone reduces risk of osteoporosis fractures in older women
Long-term follow-up study shows benefits lasted for years after randomized trialFor years after it was administered, growth hormone continued to reduce the risk of fractures and helped maintain… …read more
Growth hormone ‘treats osteoporosis in postmenopausal women’
Three years of growth hormone injections in postmenopausal women with osteoporosis continued to give bone benefits for a decade, according to the results of a randomized trial. …read more